Bank of Queensland – Sell
Bank of Queensland is under Algo Engine sell conditions and we expect selling pressure to build below the $10.00 resistance level.
Short BOQ with stops above $10.00
Crown – Buy
The current weakness in the Crown share price could be a buying opportunity. It’s unlikely that the current COVID-related operational impacts are going to deter the interested parties who have put forward takeover offers.
Continue to track the CWN share price and wait for a cross above the 10-day average.
12/8 update: CWN is now trading above the 10 day average.
18/10 update: Crown recovery continues, buy with a stop loss below $8.75
NASDAQ 100 ETF +216%
BetaShares Nasdaq 100 is under Algo Engine buy conditions and is among the best performing ETFs in our ASX ALL ETF model.
The ETF was added in January 2016 and is now up 216% after 2105 holding days.
Invocare – Algo Buy Signal
InvoCare is under Algo Engine buy conditions.
iShares S&P 500 (AUD Hedged) ETF
iShares S&P 500 AUD Hedged is under Algo Engine buy conditions.
The fund aims to provide investors with the performance of the S&P 500 Hedged AUD Index, before fees and expenses. The index is designed to measure the AUD hedged performance of large capitalisation US
equities.
Breville – Algo Buy
Breville Group is under Algo Engine buy conditions and we see price support building at $26.50
Appen – Earnings Review
Machine learning and AI specialist Appen (APX) has downgraded its earnings guidance due to the COVID-19 pandemic downturn.
The company’s guidance is for EBITDA in the range of $100 million to $110 and the company anticipates a return to strong growth in FY22.
Kogan – Algo Buy
KGN:ASX is under Algo Engine buy conditions following the correction from $25 down to $9.
Brambles – Algo Buy
Brambles is under Algo Engine buy conditions and has now been added into our model portfolio.
VanEck Global Healthcare Leaders ETF
VanEck Vectors Global Health Leaders is under Algo Engine buy conditions.
HLTH invests in a diversified portfolio of leading international developed markets (ex-Australia) companies with the best growth at a reasonable price (GARP) attributes from the global healthcare sector with the aim of providing investment returns, before fees and other costs, which track the
performance of the Index.
Level 17 Chifley Tower
2 Chifley Square
Sydney, NSW 2000
1300 614 002
Investor Signals Pty Ltd
ABN 44 143 555 453
Send our ASX Research to your Inbox
Or start a free thirty day trial for our full service, which includes our ASX Research.